Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling

被引:53
作者
Ramani, R
Mathier, M
Wang, P
Gibson, G
Tögel, S
Dawson, J
Bauer, A
Alber, S
Watkins, SC
McTiernan, CF
Feldman, AM
机构
[1] Univ Pittsburgh, Cardiovasc Inst, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Div Gastroenterol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15213 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2004年 / 287卷 / 03期
关键词
extracellular matrix; left ventricular function; myocardial infarction;
D O I
10.1152/ajpheart.00641.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to investigate the importance of tumor necrosis factor (TNF)-alpha receptor-1 (TNFR1)-mediated pathways in a murine model of myocardial infarction and remodeling. One hundred and ninety-four wild-type (WT) and TNFR1 gene-deleted (TNFR1KO) mice underwent left coronary artery ligation to induce myocardial infarction. On days 1, 3, 7, and 42, mice underwent transesophageal echocardiography. Hearts were weighed, and the left ventricle (LV) was assayed for matrix metalloproteinase (MMP)-2 and -9 activity and for tissue inhibitor of MMP (TIMP)-1 and -2 expression. Deletion of the TNFR1 gene substantially improved survival because no deaths were observed in TNFR1KO mice versus 56.4% and 18.2% in WT males and females, respectively ( P < 0.002). At 42 days, LV remodeling, assessed by LV function ( fractional area change of 31.9 +/- 7.9%, 32.2 +/- 7.7%, and 21.6 +/- 7.1% in TNFR1KO males, TNFR1KO females, and WT females, respectively, P < 0.04), and hypertrophy ( heart weight-to-body weight ratios of 5.435 +/- 0.986, 5.485 +/- 0.677, and 6.726 +/- 0.704 mg/g, P < 0.04) were ameliorated in TNFR1KO mice. MMP-9 activity was highest at 3 days postinfarction and was highest in WT males (1.9 +/- 0.4 4, 3.6 +/- 0.24, 1.15 +/- 0.28, and 1.3 +/- 1.2 ng/100 mu g protein, respectively, in TNFR1KO males, WT males, TNFR1KO females, and WT females, respectively, P < 0.002), whereas at 3 days TIMP-1 mRNA fold upregulation compared with type- and sex-matched controls was lowest in WT males (138.32 +/- 13.05, 46.74 +/- 5.43, 186.09 +/- 28.07, and 101.76 +/- 22.48, respectively, P < 0.002). MMP-2 and TIMP-2 increased similarly in all infarcted groups. These findings suggest that the benefits of TNFR1 ablation might be attributable at least in part to the attenuation of cytokine-mediated imbalances in MMP-TIMP activity.
引用
收藏
页码:H1369 / H1377
页数:9
相关论文
共 43 条
[1]  
ALLIGAND JL, 1999, J CLIN INVEST, V91, P2314
[2]   Variability of X chromosome inactivation:: effect on levels of TIMP1 RNA and role of DNA methylation [J].
Anderson, CL ;
Brown, CJ .
HUMAN GENETICS, 2002, 110 (03) :271-278
[3]   Polymorphic X-chromosome inactivation of the human TIMP1 gene [J].
Anderson, CL ;
Brown, CJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :699-708
[4]   TNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits [J].
Belosjorow, S ;
Bolle, I ;
Duschin, A ;
Heusch, G ;
Schulz, R .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (03) :H927-H930
[5]   The AP-1 site and MMP gene regulation: What is all the fuss about? [J].
Benbow, U ;
Brinckerhoff, CE .
MATRIX BIOLOGY, 1997, 15 (8-9) :519-526
[6]   Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling [J].
Cohn, JN ;
Ferrari, R ;
Sharpe, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :569-582
[7]   SEQUENCE OF HUMAN-TISSUE INHIBITOR OF METALLOPROTEINASES AND ITS IDENTITY TO ERYTHROID-POTENTIATING ACTIVITY [J].
DOCHERTY, AJP ;
LYONS, A ;
SMITH, BJ ;
WRIGHT, EM ;
STEPHENS, PE ;
HARRIS, TJR ;
MURPHY, G ;
REYNOLDS, JJ .
NATURE, 1985, 318 (6041) :66-69
[8]   Coronary microembolization:: The role of TNF-α in contractile dysfunction [J].
Dörge, H ;
Schulz, R ;
Belosjorow, S ;
Post, H ;
van de Sand, A ;
Konietzka, I ;
Frede, S ;
Hartung, T ;
Vinten-Johansen, J ;
Youker, KA ;
Entman, ML ;
Erbel, R ;
Heusch, G .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (01) :51-62
[9]   The inflammatory response in myocardial infarction [J].
Frangogiannis, NG ;
Smith, CW ;
Entman, ML .
CARDIOVASCULAR RESEARCH, 2002, 53 (01) :31-47
[10]   Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure [J].
Heymans, S ;
Luttun, A ;
Nuyens, D ;
Theilmeier, G ;
Creemers, E ;
Moons, L ;
Dyspersin, GD ;
Cleutjens, JPM ;
Shipley, M ;
Angellilo, A ;
Levi, M ;
Nübe, O ;
Baker, A ;
Keshet, E ;
Lupu, F ;
Herbert, JM ;
Smits, JFM ;
Shapiro, SD ;
Baes, M ;
Borgers, M ;
Collen, D ;
Daemen, MJAP ;
Carmeliet, P .
NATURE MEDICINE, 1999, 5 (10) :1135-1142